Article

Optic capture technique prevents PCO after pediatric cataract surgery

Posterior continuous curvilinear capsulorhexis (PCCC) with optic capture of a posterior chamber IOL is a safe and effective technique to afford stable IOL fixation and maintain visual axis clarity after cataract surgery in pediatric eyes, reported Ye Ying Jia, MD. Dr. Jia presented the outcomes from 83 eyes operated on between May 2002, and May, 2007. The patients ranged in age from 2 to 14 years (mean 5 years).

Posterior continuous curvilinear capsulorhexis (PCCC) with optic capture of a posterior chamber IOLis a safe and effective technique to afford stable IOL fixation and maintain visual axis clarityafter cataract surgery in pediatric eyes, reported Ye Ying Jia, MD.Dr. Jia presented the outcomes from 83 eyes operated on between May 2002 and May 2007. The patientsranged in age from 2 to 14 years (mean 5 years).

Cataract removal was achieved by extracapsular cataract extraction (ECCE) through an anteriorcontinuous curvilinear capsulorhexis measuring 6- to 7-mm. The PCCC was oval in shape andmeasured 3.5- by 4.5-mm. Anterior vitrectomy was not performed.

Optic capture of the PC-IOL was achieved in 79 eyes (95.2%). At 6 months after surgery,best-corrected distance visual acuity was 20/40 or better in about 52% of eyes. After follow-up of 12to 36 months, all eyes maintained a clear visual axis Complications included early anterior chamberfibrous exudation (23%) that responded to topical anti-inflammatory treatment, limited iris posteriorsynechia (16%), and superficial IOL deposits.

"Between 75% and 100% of pediatric eyes develop posterior capsule opacification after ECCE. Thetechnique of PCCC with IOL optic capture prevents this phenomenon by creating tighter contact of theIOL with the posterior capsule to prevent migration of lens epithelial cells. A Soemmering's ring isformed, the capsular sac is blocked, and a clear visual axis maintained," said Dr. Jia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
© 2025 MJH Life Sciences

All rights reserved.